Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: A cost of control analysis

Brian Bekker Hansen,S. Nuhoho,Sarah Naz Ali,Tam Dang-Tan,William J. Valentine,Samuel J. P. Malkin,Barnaby Hunt

Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: A cost of control analysis

2020

Brian Bekker Hansen
S. Nuhoho
Sarah Naz Ali
Tam Dang-Tan
William J. Valentine
Samuel J. P. Malkin
Barnaby Hunt

AbstractAims: The efficacy and safety of oral semaglutide, the first glucagon-like peptide-1 (GLP-1) receptor agonist developed for oral administration for the treatment of type 2 diabetes, was eva...

Keywords:

Pharmacology
Diabetes mellitus
Receptor
Agonist
Semaglutide
Medicine
Oral administration
Glucagon-like peptide-1
Type 2 diabetes
Intensive care medicine
Glucagon-like peptide 1 receptor
cost effectiveness

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations